Astra AB
former Swedish pharmaceutical company; merged 1999 with Zeneca Group into Astra Zeneca
Astra AB was a former international pharmaceutical company headquartered in Södertälje, Sweden. Astra was formed in 1913 and merged with the British Zeneca Group in 1999 to form AstraZeneca. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Product development was focused on therapeutics for gastrointestinal, cardiovascular and respiratory disorders and pain control. At the time of the merger, Astra was the largest Swedish pharmaceutical company. Astra also operated Astra Tech, a medical devices company, and marketed pharmaceuticals outside their primary development area, including anti-infective agents.
History
The issue of domestic industrial production of pharmaceuticals in Sweden, as opposed to manual preparations by pharmacists, had been discussed among Swedish pharmacists since mid-1890s. At this time, German and Swiss pharmaceutical companies dominated the Swedish market. For a long time, this never led to more than discussions, but in 1913 Astra was founded in Södertälje, and plans to produce some 40 pharmaceutical preparations were already drawn up. Pharmacist Knut Sjöberg became the first CEO of the company.
“Astra AB” enters the record as former Swedish pharmaceutical company; merged 1999 with Zeneca Group into Astra Zeneca. Crown Archives preserves that source wording while asking what Astra, former and Swedish can confirm, complicate or overturn.
Why this record matters
“Astra AB” is worth following because a concise public description often conceals a longer documentary argument. Here, Astra, former and Swedish provides the most credible route into that argument.
Contemporary correspondence, administrative files and participant testimony can test how later narratives organized the event or institution. The source revision retrieved here is dated Dec 21, 2025. The linked authority identifier is Q4811151. 1 of 1 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 1913 and 1999.
Official terminology may obscure informal participation, dissent or communities documented only indirectly. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Compare institutional narratives with records created by participants and affected communities. Dates and formal titles are useful anchors, but not substitutes for context.
- Event chronology
- Institutional context
- Locating named record creators
Contemporary correspondence, government or organizational records, oral histories and cited historical scholarship.
Three-step research path
- Establish the record: confirm the title “Astra AB”, its source revision and the description used here.
- Expand the search: follow Astra AB primary sources, Astra AB archive and Astra research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Astra AB”?
- What chronology connects this entry to wider political or social change?
- Which voices are present, absent or mediated by the institution?
Search terms from this dossier
This entry incorporates text from “Astra AB” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.